Normal tissue complication probability models in plan evaluation of children with brain tumors referred to proton therapy
- 31 July 2019
- journal article
- research article
- Published by Medical Journals Sweden AB in Acta Oncologica
- Vol. 58 (10) , 1416-1422
Abstract
Background: Children with brain tumors undergoing radiotherapy are at particular risk of radiation-induced morbidity and are therefore routinely considered for proton therapy (PT) to reduce the dose to healthy tissues. The aim of this study was to apply pediatric constraints and normal tissue complication probability (NTCP) models when evaluating the differences between PT and contemporary photon-based radiotherapy, volumetric modulated arc therapy (VMAT). Methods: Forty patients (aged 1-17 years) referred from Norwegian institutions to cranial PT abroad during 2014-2016 were selected for VMAT re-planning using the original CT sets and target volumes. The VMAT and delivered PT plans were compared by dose/volume metrics and NTCP models related to growth hormone deficiency, auditory toxicity, visual impairment, xerostomia, neurocognitive outcome and secondary brain and parotid gland cancers. Results: The supratentorial brain, temporal lobes, hippocampi, hypothalamus, pituitary glands, cochleas, salivary glands, optic nerves and chiasm received lower mean doses from PT. Reductions in population median NTCP were significant for auditory toxicity (VMAT: 3.8%; PT: 0.3%), neurocognitive outcome (VMAT: 3.0 IQ points decline at 5 years post RT; PT: 2.5 IQ points), xerostomia (VMAT: 2.0%; PT: 0.6%), excess absolute risk of secondary cancer of the brain (VMAT: 9.2%; PT: 6.7%) and salivary glands (VMAT: 2.8%; PT:0.5%). Across all patients, 23/38 PT plans had better or comparable estimated risks for all endpoints (within ±10% of the risk relative to VMAT), whereas for 1/38 patients all estimates were better or comparable with VMAT. Conclusions: PT reduced the volumes of normal tissues exposed to radiation, particularly low-to-intermediate dose levels, and this was reflected in lower NTCP. Of the included endpoints, substantial reductions in population medians were seen from the delivered PT plans for auditory complications, xerostomia, and risk of secondary cancers of the brain and salivary glands.Keywords
This publication has 45 references indexed in Scilit:
- Survivors of childhood and adolescent cancer: life-long risks and responsibilitiesNature Reviews Cancer, 2013
- Letter to the EditorNeuro-Oncology, 2013
- Long-Term Effects of Radiation Exposure among Adult Survivors of Childhood Cancer: Results from the Childhood Cancer Survivor StudyRadiation Research, 2010
- Region-specific radiotherapy and neuropsychological outcomes in adult survivors of childhood CNS malignanciesNeuro-Oncology, 2010
- Radiation Dose–Volume Effects in the BrainInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- Prevalence and risk factors of radiation-induced growth hormone deficiency in childhood cancer survivors: A systematic reviewCancer Treatment Reviews, 2009
- Radiation-induced hypopituitarism after cancer therapy: who, how and when to testNature Clinical Practice Endocrinology & Metabolism, 2009
- Twenty-five–year follow-up among survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor StudyBlood, 2008
- Endocrine Outcomes for Children With Embryonal Brain Tumors After Risk-Adapted Craniospinal and Conformal Primary-Site Irradiation and High-Dose Chemotherapy With Stem-Cell Rescue on the SJMB-96 TrialJournal of Clinical Oncology, 2008
- Modeling radiation dosimetry to predict cognitive outcomes in pediatric patients with CNS embryonal tumors including medulloblastomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2006